An open label, single-dose, single-period study designed to assess the pharmacokinetics and mass balance recovery, metabolite profile and metabolite identification of ([Cyclohexane-U-14C]-MBS2320) in healthy male subjects
Latest Information Update: 01 Nov 2022
At a glance
- Drugs Leramistat (Primary)
- Indications Idiopathic pulmonary fibrosis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Acronyms IST-04
- Sponsors Istesso
Most Recent Events
- 11 Oct 2022 Status changed from recruiting to completed.
- 13 Sep 2022 New trial record
- 07 Sep 2022 Status changed from not yet recruiting to recruiting.